234 related articles for article (PubMed ID: 32304024)
1. A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C.
Lu JJ; Chen M; Lv CL; Zhang R; Lu H; Cheng DH; Tang SY; Liu TT
Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):535-546. PubMed ID: 32304024
[TBL] [Abstract][Full Text] [Related]
2. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients.
Shoji K; Saito J; Nakagawa H; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Momper JD; Capparelli EV; Miyairi I
Microbiol Spectr; 2021 Oct; 9(2):e0046021. PubMed ID: 34612690
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
6. Improved vancomycin dosing in children using area under the curve exposure.
Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients.
Hambrick HR; Fei L; Pavia K; Kaplan J; Mizuno T; Tang P; Schuler E; Benoit S; Girdwood ST
Transplant Cell Ther; 2024 Jun; 30(6):614.e1-614.e11. PubMed ID: 38522579
[TBL] [Abstract][Full Text] [Related]
9. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
[TBL] [Abstract][Full Text] [Related]
10. Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.
Jing L; Liu TT; Guo Q; Chen M; Lu JJ; Lv CL
J Clin Pharm Ther; 2020 Feb; 45(1):88-96. PubMed ID: 31463971
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.
Chung JY; Jin SJ; Yoon JH; Song YG
J Korean Med Sci; 2013 Jan; 28(1):48-54. PubMed ID: 23341711
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
Sridharan K; Abbasi MY; Mulubwa M
Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.
Moffett BS; Morris J; Munoz F; Arikan AA
Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470
[TBL] [Abstract][Full Text] [Related]
16. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC
Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A
Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538
[TBL] [Abstract][Full Text] [Related]
17. Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?
DeCarolis DD; Thorson JG; Marraffa RA; Clairmont MA; Kuskowski MA
Ther Drug Monit; 2014 Oct; 36(5):632-9. PubMed ID: 25222855
[TBL] [Abstract][Full Text] [Related]
18. The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients.
Chen J; Huang X; Bu S; Chen X; Zhou J; Liu X; Guo X; Li L; Zhang J
Pharmacol Res Perspect; 2021 Dec; 9(6):e00885. PubMed ID: 34664790
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
Decker BS; Kays MB; Chambers M; Kraus MA; Moe SM; Sowinski KM
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1981-7. PubMed ID: 20616157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]